CNN legal analyst Elliot Williams predicts lawsuits against the Justice Department and The New York Times by victims whose unredacted nude images were included in the recent Epstein files dump, citing privacy violations.
The iconic outdoor apparel brand Eddie Bauer is preparing to file for Chapter 11 bankruptcy and close its physical stores across the U.S. and Canada, marking a decisive shift to a digital-first future while retaining some international retail presence.
The FIRE movement is no longer the exclusive domain of high-flying tech salaries. A growing community of middle and working-class Americans is proving that strategic frugality and disciplined investing can pave the way to financial independence decades ahead of schedule.
Chinese courts have executed four senior members of a Myanmar-based criminal organization for murder, trafficking, and running a multi-billion dollar scam operation that exploited thousands, including Chinese citizens. The move is part of a broader crackdown on cross-border cyber fraud hubs.
Indonesian authorities have conditionally lifted the ban on the Grok AI chatbot after receiving a detailed compliance plan from X Corp. The move follows regional concerns over the platform's misuse for generating explicit deepfakes.
In a major consolidation move, Eldorado Gold announces a definitive agreement to acquire Canadian copper-gold developer Foran Mining, positioning the combined entity as a significant near-term producer with a diversified North American and European asset base.
The century-old outdoor apparel brand, owned by Catalyst Brands, is preparing a Chapter 11 filing that could shutter its North American store network, while its e-commerce and wholesale operations are set for a transfer to new licensee Outdoor 5.
The Hershey Company is expanding its Jolly Rancher brand with a dual-pronged strategy: launching spicy 'Heat Wave' gummies and a limited-edition collectible box in partnership with VeeFriends. This move aims to capture the attention of younger consumers and digital-native collectors, signaling a shift in the confectionery giant's growth playbook beyond traditional chocolate.
As Baidu pivots from its search engine roots, its heavy investments in autonomous vehicle technology are beginning to yield operational results, reshaping analyst views and sparking fresh valuation discussions amidst fierce AI competition.
ExxonMobil has commenced commercial operations at a significant carbon capture and storage (CCS) facility in Louisiana, developed in partnership with CF Industries. The move signals a strategic expansion of the oil giant's low-carbon portfolio and has sparked debate among investors weighing its long-term value against current momentum.
A Utah couple with a $180,000 income sought advice on using a $7,300 bonus. Dave Ramsey's firm counsel: shore up emergency savings, attack their HELOC debt, and postpone both a long-awaited honeymoon and speculative IPO investing until their financial foundation is secure.
A Foxboro woman's two-year struggle with a defective high-end oven underscores the enduring power of state consumer protection laws, even after a manufacturer's warranty expires.
Target's Michael Fiddelke and Walmart's John Furner step into the CEO role, outlining priorities to reinvigorate growth and customer loyalty amid operational and social challenges.
As economic pressures mount, flexible remote work opportunities are evolving. We examine four proven side gigs that experts project can still generate significant weekly earnings from home in the coming years.
Garrett Motion (GTX) is drawing strong buy ratings from analysts, with a median price target suggesting over 20% upside, driven by its strategic pivot to zero-emission vehicle technologies and resilient financial profile.
A new report highlights how small and medium-sized businesses are leveraging AI, hyper-personalization, and sustainable practices not just to adapt, but to lead in a rapidly evolving marketplace.
Piper Sandler and Barclays have raised price targets for CytomX Therapeutics (CTMX), citing promising early-phase data for its experimental colorectal cancer therapy. Updated results from a larger patient cohort are expected this quarter.
Following the FDA's decision to remove the clinical hold on Intellia's Nex-Z hATTR-PN trial, analysts at Baird and H.C. Wainwright have significantly raised their price targets for the CRISPR gene-editing pioneer, citing reduced regulatory risk and a clearer path forward.
Clear Street downgrades Janux Therapeutics (JANX) to Hold, slashing its price target amid concerns over a lack of durability data for its lead candidate JANX007 and rising competitive pressures, despite a recent major collaboration deal with Bristol Myers Squibb.
Goldman Sachs has downgraded MoonLake Immunotherapeutics (MLTX) to Sell, highlighting the failed VELA-2 trial endpoint and persistent approval risks for its key drug, sonelokimab, despite a competing firm's more bullish outlook.
